Martin C. Tammemägi
Professor
Faculty of Applied Health Sciences
Brock University
Canada
Biography
Dr. Tammemägi has a strong interest in cancer epidemiology with special interests in lung cancer screening and cancer risk prediction modeling. He has been a co-investigator and remains an active analyst in the U.S. Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO), the U.S, National Lung Screening Trial (NLST), and the Pan-Canadian Early Detection of Lung Cancer Study, and is an active associate member of the U.S. NIH NCI Cancer Intervention and Surveillance Modeling Network (CISNET) lung group. Dr. Tammemägi currently also serves as the Scientific Lead on Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk.
Research Interest
Cancer epidemiology, Cancer risk prediction modeling, Cancer screening, especially lung cancer screening
Publications
-
Tammemagi M, Mayo J, Lam S. Cancer in Pulmonary Nodules Detected on First Screening CT – Reply to Correspondence to the Editor. The New England journal of medicine. 2013;369(21):2061-2.
-
McWilliams A, Tammemagi M, Mayo J, et al. Probability of cancer in pulmonary nodules detected on first screening computed tomography. New England Journal of Medicine. 2013;369;10:910-9. PMID: 24004118.
-
de Koning H, Meza R, Plevritis S, ten Haaf K, Munshi V, Jeon J, Erdogan S, Kong C, Han S, Rosmalen J, Choi S, Miller M, Moolgavkar SH, Pinsky P, Berg CD, Berrington De Gonzalez A, Black W, Tammemagi MC, Hazelton W, Feuer E, McMahon P. Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High-Risk Populations. AHRQ Publication No. 13-05196-EF-2. Rockville, MD: Agency for Healthcare Research and Quality, 2013.
-
Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS. Interstitial Lung Abnormalities in a CT Lung Cancer Screening Population: Prevalence and Progression Rate. Radiology. 2013;268(2):563-71. PMID: 23513242.
-
Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA. Targeting of low-dose CT screening according to the risk of lung-cancer death. New England Journal of Medicine. 2013;369(3):245-54. PMID: 23863051.
-
Lam S, McWilliams A, Mayo J, Tammemagi M. Computed tomography screening for lung cancer: what is a positive screen? Annals of Internal Medicine. 2013;158:289-90. PMID: 23420238.
-
Tammemagi MC, Katki H, Hocking W, Church T, Caporaso N, Kvale P, Chaturvedi A, Riley T, Commins J, Berg C. Selection criteria for lung-cancer screening. New England Journal of Medicine. 2013;368(8):728-36. PMID: 23425165.
-
Barry SA, Tammemagi MC, Penek S, Kassan EC, Dorfman CS, Riley TL, Commin J, Taylor KL. Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Journal of the National Cancer Institute. Nov 7 2012;104(21):1647-1659.
